 This trial is conducted in Europe. The aim of this clinical trial is to investigate the safety, tolerability, pharmacokinetics the determination of the concentration of the administered medication in blood over time and pharmacodynamics the determination of the effect over time and the duration of action of a long-acting growth hormone NNC126-0083 in growth hormone deficient children. 